These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 31488714)

  • 1. Neurokinin-1 receptor is an effective target for treating leukemia by inducing oxidative stress through mitochondrial calcium overload.
    Ge C; Huang H; Huang F; Yang T; Zhang T; Wu H; Zhou H; Chen Q; Shi Y; Sun Y; Liu L; Wang X; Pearson RB; Cao Y; Kang J; Fu C
    Proc Natl Acad Sci U S A; 2019 Sep; 116(39):19635-19645. PubMed ID: 31488714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel Mechanism of Endoplasmic Reticulum Stress- and c-Myc-Degradation-Mediated Therapeutic Benefits of Antineurokinin-1 Receptor Drugs in Colorectal Cancer.
    Shi Y; Wang X; Meng Y; Ma J; Zhang Q; Shao G; Wang L; Cheng X; Hong X; Wang Y; Yan Z; Cao Y; Kang J; Fu C
    Adv Sci (Weinh); 2021 Nov; 8(21):e2101936. PubMed ID: 34605226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Neurokinin-1 Receptor Antagonist Aprepitant, a New Drug for the Treatment of Hematological Malignancies: Focus on Acute Myeloid Leukemia.
    Muñoz M; Coveñas R
    J Clin Med; 2020 Jun; 9(6):. PubMed ID: 32492831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substance P prevents 1-methyl-4-phenylpyridinium-induced cytotoxicity through inhibition of apoptosis via neurokinin-1 receptors in MES23.5 cells.
    Wang SY; Chen L; Xue Y; Xia YJ
    Mol Med Rep; 2015 Dec; 12(6):8085-92. PubMed ID: 26497672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Repurposing of Non-Peptide Neurokinin-1 Receptor Antagonists as Antitumor Drugs: An Urgent Challenge for Aprepitant.
    Coveñas R; Rodríguez FD; Robinson P; Muñoz M
    Int J Mol Sci; 2023 Nov; 24(21):. PubMed ID: 37958914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-21 in Substance P-induced exosomes promotes cell proliferation and migration in human colonic epithelial cells.
    Bakirtzi K; Man Law IK; Fang K; Iliopoulos D; Pothoulakis C
    Am J Physiol Gastrointest Liver Physiol; 2019 Dec; 317(6):G802-G810. PubMed ID: 31545921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The neurokinin 1 receptor regulates peritoneal fibrinolytic activity and postoperative adhesion formation.
    Cassidy MR; Sheldon HK; Gainsbury ML; Gillespie E; Kosaka H; Heydrick S; Stucchi AF
    J Surg Res; 2014 Sep; 191(1):12-8. PubMed ID: 24836694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human acute myeloid leukemia cells express Neurokinin-1 receptor, which is involved in the antileukemic effect of Neurokinin-1 receptor antagonists.
    Molinos-Quintana A; Trujillo-Hacha P; Piruat JI; Bejarano-García JA; García-Guerrero E; Pérez-Simón JA; Muñoz M
    Invest New Drugs; 2019 Feb; 37(1):17-26. PubMed ID: 29721755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurotransmitter substance P mediates pancreatic cancer perineural invasion via NK-1R in cancer cells.
    Li X; Ma G; Ma Q; Li W; Liu J; Han L; Duan W; Xu Q; Liu H; Wang Z; Sun Q; Wang F; Wu E
    Mol Cancer Res; 2013 Mar; 11(3):294-302. PubMed ID: 23345604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in the research and application of neurokinin-1 receptor antagonists.
    Hong X; Ma J; Zheng S; Zhao G; Fu C
    J Zhejiang Univ Sci B; 2024 Feb; 25(2):91-105. PubMed ID: 38303494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human microglia and astrocytes constitutively express the neurokinin-1 receptor and functionally respond to substance P.
    Burmeister AR; Johnson MB; Chauhan VS; Moerdyk-Schauwecker MJ; Young AD; Cooley ID; Martinez AN; Ramesh G; Philipp MT; Marriott I
    J Neuroinflammation; 2017 Dec; 14(1):245. PubMed ID: 29237453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated SP/NK-1R in esophageal carcinoma promotes esophageal carcinoma cell proliferation and migration.
    Dong J; Feng F; Xu G; Zhang H; Hong L; Yang J
    Gene; 2015 Apr; 560(2):205-10. PubMed ID: 25659767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antagonism of NK-1R using aprepitant suppresses inflammatory response in rheumatoid arthritis fibroblast-like synoviocytes.
    Liu X; Zhu Y; Zheng W; Qian T; Wang H; Hou X
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1628-1634. PubMed ID: 31010320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential contribution of substance P and neurokinin A to spinal cord neurokinin-1 receptor signaling in the rat.
    Trafton JA; Abbadie C; Basbaum AI
    J Neurosci; 2001 May; 21(10):3656-64. PubMed ID: 11331395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substance P accelerates the progression of human esophageal squamous cell carcinoma via MMP-2, MMP-9, VEGF-A, and VEGFR1 overexpression.
    Mohammadi F; Javid H; Afshari AR; Mashkani B; Hashemy SI
    Mol Biol Rep; 2020 Jun; 47(6):4263-4272. PubMed ID: 32436041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SP/NK-1R promotes gallbladder cancer cell proliferation and migration.
    Deng XT; Tang SM; Wu PY; Li QP; Ge XX; Xu BM; Wang HS; Miao L
    J Cell Mol Med; 2019 Dec; 23(12):7961-7973. PubMed ID: 30903649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Neurokinin-1 Receptor Is Essential for the Viability of Human Glioma Cells: A Possible Target for Treating Glioblastoma.
    Muñoz MF; Argüelles S; Rosso M; Medina R; Coveñas R; Ayala A; Muñoz M
    Biomed Res Int; 2022; 2022():6291504. PubMed ID: 35434136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substance P (SP)-neurokinin-1 receptor (NK-1R) alters adipose tissue responses to high-fat diet and insulin action.
    Karagiannides I; Stavrakis D; Bakirtzi K; Kokkotou E; Pirtskhalava T; Nayeb-Hashemi H; Bowe C; Bugni JM; Nuño M; Lu B; Gerard NP; Leeman SE; Kirkland JL; Pothoulakis C
    Endocrinology; 2011 Jun; 152(6):2197-205. PubMed ID: 21467195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurokinin-1 receptor expression and antagonism by the NK-1R antagonist maropitant in canine melanoma cell lines and primary tumour tissues.
    Borrego JF; Huelsmeyer MK; Pinkerton ME; Muszynski JL; Miller SA; Kurzman ID; Vail DM
    Vet Comp Oncol; 2016 Jun; 14(2):210-24. PubMed ID: 24751104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The substance P/neurokinin-1 receptor system in lung cancer: focus on the antitumor action of neurokinin-1 receptor antagonists.
    Muñoz M; González-Ortega A; Rosso M; Robles-Frias MJ; Carranza A; Salinas-Martín MV; Coveñas R
    Peptides; 2012 Dec; 38(2):318-25. PubMed ID: 23026680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.